Jan 8 (Reuters) - Cellink Ab:
* CELLINK SIGNS COLLABORATION AGREEMENT WITH CTIBIOTECH FOR BIOPRINTING OF PATIENT-SPECIFIC CANCER TUMORS
* ‍COST OF DEVELOPING A NEW DRUG IS NOW ESTIMATED AT $2.5 BILLION OVER 10 YEARS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 